744 related articles for article (PubMed ID: 28780930)
1. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
2. Oncology pharmaceutical funding in New Zealand: a different approach and a proposal.
Beatty PA; Laking GR
J Oncol Pract; 2015 May; 11(3):249-51. PubMed ID: 25829524
[No Abstract] [Full Text] [Related]
3. Revisiting Repurposing.
Sharlow ER
Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
[TBL] [Abstract][Full Text] [Related]
4. Creating New Economic Incentives for Repurposing Generic Drugs for Unsolved Diseases Using Social Finance.
Bloom BE
Assay Drug Dev Technol; 2015 Dec; 13(10):606-11. PubMed ID: 26284286
[TBL] [Abstract][Full Text] [Related]
5. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
6. In Silico Oncology Drug Repositioning and Polypharmacology.
Cheng F
Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
[TBL] [Abstract][Full Text] [Related]
7. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
Vassal G; Rousseau R; Blanc P; Moreno L; Bode G; Schwoch S; Schrappe M; Skolnik J; Bergman L; Bradley-Garelik MB; Saha V; Pearson A; Zwierzina H
Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.
American Society of Clinical Oncology
J Oncol Pract; 2018 Mar; 14(3):187-192. PubMed ID: 29091534
[No Abstract] [Full Text] [Related]
9. Oncology business development global summit.
Bockman JM; Nalam S
IDrugs; 2005 Jan; 8(1):37-40. PubMed ID: 15650940
[No Abstract] [Full Text] [Related]
10. An Oncologist's Letter to Santa: Bring Me Drugs!
Tempero M
J Natl Compr Canc Netw; 2018 Dec; 16(12):1411. PubMed ID: 30545986
[No Abstract] [Full Text] [Related]
11. Pricing increases for cancer drugs sparks investigation.
Venkatesan P
Lancet Oncol; 2017 Jul; 18(7):e372. PubMed ID: 28552213
[No Abstract] [Full Text] [Related]
12. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
American Society of Clinical Oncology
J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877
[No Abstract] [Full Text] [Related]
13. Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A; Dueñas-González A
Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
[TBL] [Abstract][Full Text] [Related]
14. Drug rediscovery to prevent off-label prescription reduces health care costs: the case of tioguanine in the Netherlands.
Mulder CJ; van Asseldonk DP; de Boer NK
J Gastrointestin Liver Dis; 2014 Jun; 23(2):123-5. PubMed ID: 24949602
[No Abstract] [Full Text] [Related]
15. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.
Power A; Berger AC; Ginsburg GS
JAMA; 2014 May; 311(20):2063-4. PubMed ID: 24867009
[No Abstract] [Full Text] [Related]
16. Can you teach old drugs new tricks?
Nosengo N
Nature; 2016 Jun; 534(7607):314-6. PubMed ID: 27306171
[No Abstract] [Full Text] [Related]
17. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
Lago SG; Bahn S
ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
K W To K; Cho WCS
Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
[TBL] [Abstract][Full Text] [Related]
19. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
[No Abstract] [Full Text] [Related]
20. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
